XTL Biopharmaceuticals to acquire Kitov Pharmaceuticals - MarketLine Financial Deals

XTL Biopharmaceuticals to acquire Kitov Pharmaceuticals

XTL Biopharmaceuticals to acquire Kitov Pharmaceuticals - MarketLine Financial Deals
XTL Biopharmaceuticals to acquire Kitov Pharmaceuticals
Published Jun 19, 2012
2 pages — Published Jun 19, 2012
Price US$ 20.00  |  Buy this Report Now

About This Report

  
Abstract:

XTL Biopharmaceuticals, Ltd., a biopharmaceutical company, has agreed to acquire Kitov Pharmaceuticals, Ltd.

  
Source:
Document ID
MA113703_120621
Country
Ticker
XTL=IL
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "XTL Biopharmaceuticals to acquire Kitov Pharmaceuticals" Jun 19, 2012. Alacra Store. Dec 04, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/XTL-Biopharmaceuticals-to-acquire-Kitov-Pharmaceuticals-2052-83092>
  
APA:
MarketLine Financial Deals. (2012). XTL Biopharmaceuticals to acquire Kitov Pharmaceuticals Jun 19, 2012. New York, NY: Alacra Store. Retrieved Dec 04, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/XTL-Biopharmaceuticals-to-acquire-Kitov-Pharmaceuticals-2052-83092>
  
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.